Search Results 1791-1800 of 21363 for anti-TNF drugs
Has any unresolved toxicity grade > 1 from previous anti-cancer therapy. Subject use of immunosuppressive medication within 14 days before the Cycle 1 Day 1:.
Participation eligibility · Cisplatin ineligibility is defined as meeting one of the following criteria: · Anti PD-1/PD-L1 therapy administered as part of ...
Side Effects. Drug information provided by: Merative, Micromedex®. Along with its needed effects, a medicine may cause some unwanted effects. Although not ...
Patients receiving treatment with hematopoietic growth factors or anti-vasculogenesis or anti-angiogenesis treatment (e.g., anti-VEGF). Patients requiring ...
Elizabeth Stewart, a Mayo Clinic gynecologist and researcher, recently published a review on these approved fibroid medications. They are called oral ...
Patient with aggressive NHL must have received prior therapy - at a minimum: Anti-CD20 monoclonal antibody unless tumor is CD20 negative; and; An ...
You will also be required to have a pregnancy test every month during your treatment. If you miss a period while you are using this medicine, tell your doctor ...
... anti-human leukocyte antigen (HLA) antibody specific for their deceased donor. It is our hypothesis that blockade of terminal complement activation with ...
... treatment regimens (including anti-CD20 mAb and an alkylating agent). For MZL patients: Previously received at least 2 prior lines of systemic therapy ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Make a gift before July 31 and it can go twice as far to fight cancer.